The Mankind Pharma MD further revealed that flavors like kala khatta and sabudana were merely marketing gimmicks and ...

Mankind Pharma's shares are in focus following a 16.5% YoY decline in Q3 net profit to Rs 385 crore, despite strong revenue ...

Not all flavoured condoms are created equal. Some sell more in south India, while others have found a niche in the north, per a leading condom brand in India.

Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 3050 in its ...

In the latest episode of the podcast ‘Figuring Out With Raj Shamani’, Rajeev Juneja of Mankind Pharma discussed regional ...

Mankind Pharma Ltd.'s share price declined more than 5% during early trade on Friday after the company's third-quarter ...

Stay informed with Hindustan Times' live updates! Track the latest lifestyle news including fashion trends, style guide & ...

NDTV Profit tracks what analysts are saying about various stocks and sectors. Here are the analyst calls to keep an eye out ...

Mankind Pharma's domestic business revenues grew by 16 per cent year-on-year, reaching Rs 2,773 crore in Q3FY25, compared to Rs 2,400 crore in Q3FY24. The company’s consumer healthcare segment saw a ...

Most pharma stocks traded in the red during Friday’s session, with the Nifty Pharma index falling 2.19% at 21,854.15. Dr.

Mankind Pharma shed 2.76% to Rs 2,560.05 after the company's consolidated net profit declined 16.2% to Rs 380.23 crore in Q3 FY25 as against Rs 453.76 crore posted in Q3 FY24.

Mankind Pharma's Q3 net profit was impacted by the $1.6 billion acquisition of Bharat Serums and Vaccines (BSV), which came ...